Insider Selling: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Director Sells 21,700 Shares of Stock
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) Director Amy W. Schulman sold 21,700 shares of Alnylam Pharmaceuticals stock in a transaction on Wednesday, May 29th. The stock was sold at an average price of $148.60, for a total value of $3,224,620.00. Following the transaction, the director now directly owns 8,436 shares of the company’s […]
More Stories
Judge Warns Trump’s Order May Violate Previous Ruling on Sanctuary Cities
By Sam Dorman A federal judge has admonished the Trump administration not to use a recent executive order on so-called...
Price T Rowe Associates Inc. MD Has $1.23 Million Holdings in Embecta Corp. (NASDAQ:EMBC)
Price T Rowe Associates Inc. MD raised its stake in Embecta Corp. (NASDAQ:EMBC – Free Report) by 6.8% during the...
Hsbc Holdings PLC Sells 4,843 Shares of Stewart Information Services Co. (NYSE:STC)
Hsbc Holdings PLC lowered its position in shares of Stewart Information Services Co. (NYSE:STC – Free Report) by 50.4% in...
Tower Research Capital LLC TRC Reduces Holdings in TFS Financial Co. (NASDAQ:TFSL)
Tower Research Capital LLC TRC lowered its stake in TFS Financial Co. (NASDAQ:TFSL – Free Report) by 20.4% during the...
Pet Valu (TSE:PET) Price Target Raised to C$36.00
Pet Valu (TSE:PET – Free Report) had its target price boosted by Raymond James from C$34.00 to C$36.00 in a...
CRISPR Therapeutics (NASDAQ:CRSP) Given New $47.00 Price Target at The Goldman Sachs Group
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target lowered by equities research analysts at The Goldman Sachs...